<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(4)</volume><submitter>Kudo M</submitter><journal>Liver cancer</journal><pagination>305-311</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6249592</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma.</pubmed_title><pmcid>PMC6249592</pmcid><pubmed_authors>Kudo M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Ramucirumab as Second-Line Systemic Therapy in Hepatocellular Carcinoma.</name><description/><dates><release>2018-01-01T00:00:00Z</release><publication>2018 Oct</publication><modification>2025-04-21T16:25:32.926Z</modification><creation>2025-04-21T16:25:32.926Z</creation></dates><accession>S-EPMC6249592</accession><cross_references><pubmed>30488020</pubmed><doi>10.1159/000492534</doi></cross_references></HashMap>